You will receive alerts when there are new announcements on Acusphere, Inc.
Only registered members can use this feature.
Acusphere is a specialty pharmaceutical company, primarily focused on the development of Imagify™ (Perflubutane Polymer Microspheres) for Injectible Suspension, a cardiovascular drug for the detection of coronary artery disease (CAD).
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.